netFormulary
 Report : A-Z HCD items in Formulary 19/03/2019 07:52:26
[Back]
 
Section Status Black Triangle Name
08.01.05 Formulary Black Triangle Abemaciclib Verzenios®
08.01.05 Formulary Black Triangle Afatinib Giotrif®
08.01.05 Formulary Black Triangle Alectinib Alecensa®
08.01.05 Formulary Black Triangle Atezolizumab Tecentriq®
08.01.05 Formulary Black Triangle Avelumab Bavencio®
08.01.05 Restricted Use Black Triangle Axicabtagene ciloleucel YESCARTA®
08.01.05 Formulary Black Triangle Binimetinib Mektovi®
08.01.05 Formulary Black Triangle Bosutinib Bosulif®
08.01.05 Formulary Black Triangle Brentuximab vedotin Adcetris®
08.01.05 Formulary Black Triangle Brigatinib Alunbrig®
08.01.05 Formulary Black Triangle Cabozantinib Cometriq®, Cabometyx®
08.01.05 Formulary Black Triangle Ceritinib Zykadia®
08.01.05 Formulary Black Triangle Crizotinib Xalkori®
08.01.05 Non Formulary Black Triangle Dabrafenib Tafinlar®
08.01.05 Formulary Black Triangle Dabrafenib Tafinlar®
05.03.03.02 Formulary Black Triangle Daclatasvir Daklinza®
08.01.05 Formulary Black Triangle Daratumumab DARZALEX®
05.03.03.02 Formulary Black Triangle Dasabuvir Exviera®
08.01.05 Restricted Use Black Triangle Dinumtuximab Qarziba®
13.05.03 Formulary Black Triangle Dupilumab Dupixent®
08.01.05 Restricted Use Black Triangle Durvalumab Imfinzi®
05.03.03.02 Formulary Black Triangle Elbasvir with Grazoprevir Zepatier®
02.11 Restricted Use Black Triangle Emicizumab Hemlibra®
08.01.05 Formulary Black Triangle Encorafenib Braftovi®
08.01.05 Formulary Black Triangle Gemtuzumab ozogamicin MYLOTARG®
05.03.03.02 Formulary Black Triangle Glecaprevir with Pibrentasvir Maviret®
08.01.05 Formulary Black Triangle Idelalisib Zydelig®
08.01.05 Formulary Black Triangle Inotuzumab ozogamicin BESPONSA®
08.01.05 Formulary Black Triangle Ixazomib Ninlaro®
08.01.05 Formulary Black Triangle Lenvatinib Kisplyx®, Lenvima®
08.01.05 Formulary Black Triangle Lutetium (177Lu) oxodotreotide Lutathera®
14.04 Formulary Black Triangle Meningococcal group B Vaccine Bexsero®
08.01.05 Formulary Black Triangle Midostaurin Rydapt®
08.01.05 Formulary Black Triangle Nintedanib  Vargatef®, Ofev®
08.01.05 Formulary Black Triangle Niraparib Zejula®
08.01.05 Non Formulary Black Triangle Nivolumab Opdivo®
08.01.05 Formulary Black Triangle Nivolumab Opdivo®
08.02.03 Formulary Black Triangle Obinutuzumab  Gazyvaro®
08.02.04 Formulary Black Triangle Ocrelizumab OCREVUS®
08.01.05 Restricted Use Black Triangle Olaratumab Lartruvo®
05.03.03.02 Formulary Black Triangle Ombitasvir with Paritaprevir and Ritonavir Viekirax®
08.01.05 Formulary Black Triangle Osimertinib Tagrisso®
08.01.05 Non Formulary Black Triangle Padeliporfin TOOKAD®
08.01.05 Formulary Black Triangle Palbociclib IBRANCE®
08.01.05 Formulary Black Triangle Pembrolizumab Keytruda®
08.01.05 Formulary Black Triangle Ponatinib Iclusig®
08.01.05 Formulary Black Triangle Regorafenib Stivarga®
08.01.05 Formulary Black Triangle Ribociclib Kisqali®
05.03.03.02 Formulary Black Triangle Sofosbuvir Sovaldi®
05.03.03.02 Formulary Black Triangle Sofosbuvir with ledipasvir Harvoni®
05.03.03.02 Formulary Black Triangle Sofosbuvir with velpatasvir Epclusa®
05.03.03.02 Formulary Black Triangle Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi®
01.09 Formulary Black Triangle Telotristat Xermelo®
08.01.05 Restricted Use Black Triangle Tisagenlecleucel Kymriah®
08.01.05 Formulary Black Triangle Tivozanib Fotivda®
08.01.05 Formulary Black Triangle Trametinib Mekinist®
08.01.05 Non Formulary Black Triangle Trametinib Mekinist®
08.01.05 Formulary Black Triangle Trastuzumab emtansine Kadcyla®
08.01.05 Non Formulary Black Triangle Vandetanib Caprelsa®
08.01.05 Formulary Black Triangle Venetoclax Venclyxto®
08.01.05 Non Formulary Black Triangle Vismodegib Erivedge®
Dorset